Lisdexamfetamine dimesylate
NDC 0480-3569, Lisdexamfetamine dimesylate, capsule, from Teva Pharmaceuticals, Inc..
- Product NDC
- 0480-3569
- Status
- Listed
- Labeler
- Teva Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202802
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE50 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0480-3569-01 | 00480356901 | 100 CAPSULE in 1 BOTTLE (0480-3569-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c32b5dce-2de4-4db0-a4ba-d2ce3b0a32fcNADAC price for package 00480356901
GET /v1/drugs/nadac/00480356901
Use it
Look up 0480-3569 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0480-3569. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.